President Donald Trump told The New York Times he has not used GLP-1 weight-loss drugs like Ozempic or Wegovy but joked he “probably should.” The disclosure comes as these medications spark debates over healthcare costs and insurance coverage. Trump’s remarks highlight both his personal health and his administration’s policies aimed at lowering drug prices, showing the drugs’ growing political and cultural relevance.
Related Posts
Explosive in house or on bike? Malegaon blast judgement flags gaps in probe
A special NIA court’s acquittal in the 2008 Malegaon blast case has revealed significant contradictions between the ATS and NIA investigations. The court cited flawed […]
‘He lives in his own world’: Delhi HC pulls up Ramdev over ‘Sharbat jihad’ row
The Delhi High Court has found Yoga guru Ramdev in prima facie contempt for violating a previous order regarding his “sharbat jihad” remarks against Hamdard’s […]
The Ayyappa awaits: Sabarimala supreme’s sanctum nears Supreme Court’s final verdict
In 2006, the Indian Young Lawyers Association approached the Supreme Court of India, arguing that barring women violated constitutional guarantees of equality and freedom of […]